MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21037/jtd-2025-1105

Медицинская библиотека · Journal of thoracic disease · 2025

Risk factors and clinical outcomes of serum Aspergillus galactomannan antigen (AGA) positivity in lung transplantation.

Kamar Amanda, Miyashita Yudai, Kaiho Taisuke, Chang Austin, Thomae Benjamin Louis, Arunachalam Ambalavanan, Kurihara Chitaru

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Lung transplantation (LTx) remains a life-saving intervention for patients with end-stage lung diseases, yet complications such as infections, rejection, and thromboembolic events hinder long-term outcomes. Aspergillus galactomannan antigen (AGA) is a fungal biomarker traditionally used for diagnosing invasive pulmonary aspergillosis, but its broader clinical significance in LTx remains unclear. This study aimed to identify risk factors for serum AGA positivity after LTx and to evaluate whether AGA positivity is associated with postoperative infections, thromboembolic events, and survival.

METHODS

This retrospective study analyzed 293 lung transplant recipients at Northwestern University from January 2018 to June 2023. Patients were stratified based on AGA positivity, and demographic, intraoperative, and postoperative outcomes were compared. The association between AGA positivity, postoperative complications, and survival outcomes was evaluated using Cox proportional hazards and logistic regression models.

RESULTS

AGA positivity was detected in 24% of patients, primarily within the first 100 days post-transplant. AGA-positive patients had significantly higher rates of respiratory infections (88.7% vs. 47.8%, P<0.0001) and pulmonary embolism (23.9% vs. 12.6%, P=0.04). AGA positivity was independently associated with increased infection risk (hazard ratio: 2.47, 95% confidence interval: 1.68-3.65, P<0.0001). Key predictors of AGA positivity included older age, chronic kidney disease (CKD), and prolonged ischemic time, whereas female donor status was protective.

CONCLUSIONS

Serum AGA positivity is an early biomarker for increased infectious and thrombotic complications in lung transplant recipients. Routine AGA surveillance in post-transplant management may facilitate early identification of high-risk patients, allowing for timely interventions. Further prospective studies are warranted to assess the utility of AGA monitoring in optimizing lung transplant outcomes.

Для цитирования: Kamar Amanda, Miyashita Yudai, Kaiho Taisuke, Chang Austin, Thomae Benjamin Louis, Arunachalam Ambalavanan, Kurihara Chitaru. Risk factors and clinical outcomes of serum Aspergillus galactomannan antigen (AGA) positivity in lung transplantation.. Journal of thoracic disease. 2025. DOI: 10.21037/jtd-2025-1105.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.